We want to learn about your therapeutic program needs.
RoosterBio accelerates human mesenchymal stem/stromal cell (hMSC) and extracellular vesicle (EV) product and process development to fuel the rapid implementation of scalable advanced therapies. Our high-quality cGMP hMSCs, bioprocess media, genetic engineering tools, and EV production solutions are supported by Type 2 Master Files and paired with expert scalable bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing in less than 1 year at reduced cost and increased productivity.